Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19
Zhenzhou Wang1, Zhe Du1, Fengxue Zhu1
1Trauma Center, National Center for Trauma Medicine, Key Laboratory of Trauma and Neural Regeneration, Peking University People's Hospital, Beijing 100044, China.
Insights
High glycosylated hemoglobin (HbA1c) levels in COVID-19 patients correlate with increased inflammation and poorer prognosis. Monitoring HbA1c aids in assessing COVID-19 severity and patient outcomes.
Area of Science:
- Medical Research
- Infectious Diseases
- Endocrinology
Background:
- Diabetes mellitus is a known risk factor for severe COVID-19.
- The interplay between glycosylated hemoglobin (HbA1c), inflammation, and COVID-19 prognosis remains under-explored.
Purpose of the Study:
- To investigate the association between HbA1c levels and markers of inflammation, hypercoagulability, and oxygen saturation in COVID-19 patients.
- To evaluate the prognostic value of HbA1c in COVID-19 patients.
Main Methods:
- Retrospective analysis of 132 COVID-19 patients who had HbA1c testing.
- Collected demographic, clinical, laboratory, and outcome data.
- Categorized patients into three groups based on blood glucose status.
Main Results:
- Significant differences in SaO2, serum ferritin, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen (Fbg), and IL6 levels were observed across groups.
- Elevated HbA1c correlated positively with serum ferritin, CRP, Fbg, and ESR.
- A negative correlation was found between HbA1c and SaO2.
Conclusions:
- High HbA1c levels are linked to inflammation, hypercoagulability, and reduced oxygen saturation in COVID-19 patients.
- COVID-19 patients with diabetes exhibit a higher mortality rate (27.7%).
- HbA1c measurement post-admission is valuable for assessing COVID-19 patient prognosis.
Background:
Diabetes is a risk factor for the progression and prognosis of coronavirus disease (COVID-19), but the relationship between glycosylated hemoglobin (HbA1c) level, inflammation, and prognosis of COVID-19 patients has not been explored.
Methods:
This was a retrospective study of COVID-19 patients who underwent an HbA1c test. Their demographic data, medical history, signs and symptoms of COVID-19, laboratory test results, and final outcomes of COVID-19 treatment were collected and analyzed.
Results:
A total of 132 patients were included and divided into three groups based on their blood glucose status. There were significant differences in SaO2, serum ferritin level, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen (Fbg) level, and IL6 level among the three groups. A pairwise comparison of the groups showed that groups B and C were significantly different from group A in terms of CRP, ESR, and Fbg, IL6, and serum ferritin levels (P < 0.05). Correlation analysis showed that there was a linear negative correlation between SaO2 and HbA1c (r = -0.22, P = 0.01), while there was a linear positive correlation between serum ferritin, CRP, Fbg, and ESR levels and HbA1c (P < 0.05).
Conclusions:
High HbA1c level is associated with inflammation, hypercoagulability, and low SaO2 in COVID-19 patients, and the mortality rate (27.7%) is higher in patients with diabetes. Determining HbA1c level after hospital admission is thus helpful assessing inflammation, hypercoagulability, and prognosis of COVID-19 patients.
Related Concept Videos
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Proteoglycans
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Coronary Artery Disease I: Introduction
Diabetes Mellitus: Type 2 and Gestational
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...


